참고문헌
- Taylor, C. T. and Colgan, S. P. : Therapeutic targets for hypoxiaelicited pathways. Pharm. Res. 16, 1498 (1999). https://doi.org/10.1023/A:1011936016833
- Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., Fujii-Kuriyama, Y. and Kato, S. : Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545 (2003). https://doi.org/10.1038/nature01606
-
Wang, G. L., Jiang Bing-Hua., Rue, E. A. and Semenza, G. L. : Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular
$O_2$ tension. Proc. Natl. Acad. Sci. USA 92, 5510 (1995). https://doi.org/10.1073/pnas.92.12.5510 - Brunnberg, S., Pettersson, K., Rydin, E., Matthews, J., Hanberg, A. and Pongratz, I. : The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 100, 6517 (2003). https://doi.org/10.1073/pnas.1136688100
- Gu, Y.-Z., Hogenesch, J. B. and Bradfield, C. A. : The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519 (2000). https://doi.org/10.1146/annurev.pharmtox.40.1.519
- Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M. and Gustafsson, J. A. : Mechanisms of estrogen action. Physiol. Rev. 81, 1535 (2001).
- Kato, S. : Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 8, 3 (2001). https://doi.org/10.1007/BF02967472
- Weatherman, R. V. and Scanlan, T. S. : Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. J. Biol. Chem. 276, 3827 (2001). https://doi.org/10.1074/jbc.M005414200
- Kelly, M. J. and Levin, E. R. : Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab. 12, 152 (2001). https://doi.org/10.1016/S1043-2760(01)00377-0
- Lonard, D. M. and O'Malley, B. W. : Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell. 27, 691 (2007). https://doi.org/10.1016/j.molcel.2007.08.012
- Shao, W. and Brown, M. : Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res. 6, 39 (2004). https://doi.org/10.1186/bcr742
- Stoner, M., Saville, B., Wormke, M., Dean, D., Burghardt, R. and Safe, S. : Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol. Endocrinol. 16, 2231 (2002). https://doi.org/10.1210/me.2001-0347
- Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J. and van der Wall, E. : Levels of hypoxiainducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93, 309 (2001). https://doi.org/10.1093/jnci/93.4.309
- Kazi, A. A. and Koos, R. D. : Estrogen-induced activation of hypoxia-inducible factor-1 alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 148, 2363 (2007). https://doi.org/10.1210/en.2006-1394